Company intelligence / Profile preview

Eco Esphera

Hamilton, Ontario, Canadasphera.com ↗

Ownership: Private
Development stage: Other

Overview

Esphera SynBio is developing a proprietary synthetic biology platform to engineer producer cells that generate designer exosomes capable of delivering therapeutic payloads—including proteins and RNAs—directly to targeted cell types. Their lead application focuses on cancer vaccines, with additional programs targeting infectious diseases. The company has closed seed financing and is advancing toward clinical candidate selection; no clinical results yet as all programs are pre-clinical.

Therapeutic areas: OncologyInfectious Diseases
Modalities: Exosome-based therapyRNA therapyProtein
Industry: Biotech

Partnerships

FACITGKCC LLC

Beyond the preview

Go deeper on Eco Esphera.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eco Esphera.

Explore the full profile